Identification of a 'snapshot' of co-expressed angiogenic markers in laser-dissected vessels from unstable carotid plaques with targeted arrays

Journal of Vascular Research

Volumn 47, Issue 4, 2010, Pages 323-335

  Slevin, M ^a,b   Turu, M M ^b   Rovira, N ^b   Luque, A ^b   Baldellou, M ^b   Krupinski, J ^c   Badimon, L ^b  

^a MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c HOSPITAL MÚTUA DE TERRASSA   (Spain)

Author keywords

Angiogenesis; Atherosclerosis; Carotid plaques; Laser capture microdissection

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN RECEPTOR; ENDOGLIN; MEMBRANE PROTEIN; NOTCH3 RECEPTOR; PROTEIN DELTA LIKE 4; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIOGENESIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CAROTID PLAQUE; CLINICAL ARTICLE; ENDARTERECTOMY; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LASER MICRODISSECTION; MALE; MICROVASCULATURE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER;

AGED; ANGIOGENIC PROTEINS; ANGIOPOIETIN-1; ANTIGENS, CD; CAROTID ARTERIES; CAROTID STENOSIS; DISSECTION; ENDARTERECTOMY, CAROTID; ENDOSTATINS; GENE EXPRESSION PROFILING; GENETIC MARKERS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LASERS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PHYSIOLOGIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; RECEPTOR, TIE-2; RECEPTORS, CELL SURFACE; RECEPTORS, IMMUNOLOGIC; RECEPTORS, NOTCH; RUPTURE; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 72049098842     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000265566     Document Type: Article

References (43)

1. Libby P: Inflammatory mechanisms: the molecular basis of inflammation and disease. Nutr Rev 2007; 65: 14 0-14 6.
2. Moulton KS: Angiogenesis in atherosclerosis: gathering evidence beyond speculation. Curr Opin Lipidol 2006; 17:548-555.
3. Moulton KS, Vakili K, Zurakowski D, Soli-man M, Butterfield C, Sylvin E, Lo KM, Gillies S, Javaherian K, Folkman J: Inhibition of plaque neovascularization reduces macro-phage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci 2003; 10 0: 4736-4741.
4. Mofidi R, Crotty TB, McCarthy P, Sheehan SJ, Mehigan D, Keaveny TV: Association between plaque instability, angiogenesis and symptomatic carotid occlusive disease. Br J Surg 20 01; 88: 945-950.
5. Mofidi R, Powell TI, Crotty T, Mehigan D, Macerlaine D, Keaveny TV: Angiogenesis in carotid atherosclerotic lesions is associated with timing of ischemic neurological events and presence of computed tomographic cerebral infarction in the ipsilateral cerebral hemisphere. Ann Vasc Surg 2008; 22:266-272.
6. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1:27-31.
7. Dunmore BJ, McCarthy MJ, Naylor AR, Brindle NPJ: Carotid plaque instability and ischaemic symptoms are linked to immaturity of microvessels within plaques. J Vasc Surg 2007; 45: 155-159.
8. Juan-Babot JO, Martínez-González J, Ber-rozpe M, Badimon L: Neovascularization in human coronary arteries with lesions of different severity. Rev Esp Cardiol 2003; 56: 978-986.
9. Tureyen K, Vemuganti R, Salamat MS, Dempsey RJ: Increased angiogenesis and an-giogenic gene expression in carotid artery plaques from symptomatic stroke patients. Neurosurgery 2006; 58:971-977.
10. Slevin M, Elasabi A, Miguel-Turu M, Krupin-ski J, Badimon L, Gaffney J: Identification of differential protein expression associated with development of unstable human carotid plaques. Am J Pathol 2006; 168:1004-1021.
11. Vemuganti R, Dempsey RJ: Carotid atherosclerotic plaques from symptomatic stroke patients share the molecular fingerprints to develop in a neoplastic fashion: a microarray analysis study. Neuroscience 2005; 131:359-374.
12. Ding S, Li C, Lin S, Yang Y, Liu D, Han Y, Zhang Y, Li L, Zhou L, Kumar S: Comparative evaluation of microvessel density determined by CD34 or CD105 in benign and malignant gastric lesions. Hum Pathol 2006; 37: 861-866.
13. Gallagher WM, Bergin OE, Rafferty M, Kelly ZD, Nolan IM, Fox EJ, Culhane AC, Mc-Ardle L, Fraga MF, Hughes L, Currid CA, O'Mahoney F, Bryne A, Murphy AA, Moss C, McDonnell S, Stallings RL, Plumb JA, Es-teller M, Brown R, Dervan PA, Easty DJ: Multiple markers for melanoma progression regulated by DNA methylation: insights from transcriptomic studies. Carcinogenesis 2005; 26:1856-1867.
14. Stary HC, Chandler AB, Dinsmore RE, Fus-ter V, Glagov S, Insull W Jr, Rosenfeld ME, Schwartz CJ, Wagner WD, Wissler RW: A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol 1995; 15: 1512-1531.
15. Shibuya M: Vascular endothelial growth factor receptor-1 (VEGFR-1/Flt-1): a dual regulator for angiogenesis. Angiogenesis 2006; 9: 225-230.
16. Piao M, Tokunaga O: Significant expression of endoglin (CD105), TGFß-1 and TGF-ß R-2 in the atherosclerotic aorta: an immuno-histological study. J Atheroscler Thromb 2006; 13:82-89.
17. Bhati R, Patterson C, Livasy CA, Fan C, Ke-telsen D, Hu Z, Reynolds E, Tanner C, Moore DT, Gabrielli F, Perou CM, Klauber-DeMore N: Molecular characterization of human breast tumor vascular cells. Am J Pathol 2008; 172:1381-1390.
18. Pen A, Moreno MJ, Martin J, Stanimirovic DB: Molecular markers of extracellular matrix remodeling in glioblastoma vessels: microarray study of laser-captured glioblastoma vessels. Glia 2007; 55:559-572.
19. Roy S, Patel D, Khanna S, Gordillo GM, Biswas S, Friedman A, Sen CK: Transcrip-tome-wide analysis of blood vessels laser captured from human skin and chronic wound-edge tissue. Proc Natl Acad Sci USA 2007; 104: 14472-14477.
20. Jones MC, Caswell PT, Moran-Jones K, Roberts M, Barry ST, Gampel A, Mellor H, Norman JC: VEGFR1 (Flt1) regulates Rab4 recycling to control fibronectin polymerization and endothelial vessel branching. Traffic 2009; 10:754-766.
21. Hirashima M: Regulation of endothelial cell differentiation and arterial specification by VEGF and Notch signaling. Anat Sci Int 2009; 84: 95-101.
22. Trindade A, Kumar SR, Scehnet JS, Lopes-da-Costa L, Becker J, Jiang W, Liu R, Gill PS, Duarte A: Overexpression of delta-like 4 induces arterialization and attenuates vessel formation in developing mouse embryos. Blood 2008; 112:1720-1729.
23. Claxton S, Fruttiger M: Periodic Delta-like 4 expression in developing retinal arteries. Gene Expr Patterns 2004; 5:123-127.
24. Hellstrom M, Phng LK, Hofmann JJ, Wall-gard E, Coultas L, Lindblom P, Alva J, Nils-son AK, Karisson L, Gaiano N, Yoon K, Ros-sant J, Iruela-Arispe ML, Kalen M, Gerhardt H, Betsholtz C: Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature 2007; 445: 776-780.
25. Yan M, Plowman GD: Delta-like 4/Notch signaling and its therapeutic implications. Clin Cancer Res 2007; 13: 7243-7246.
26. Segarra M, Williams CK, Sierra Mde L, Bernardo M, McCormick PJ, Maric D, Regino C, Choyke P, Tosato G: Dl l4 ac tivat ion of Notch signaling reduces tumor vascularity and inhibits tumor growth. Blood 2008; 112:1904-1911.
27. Li JL, Sainson RC, Shi W, Leek R, Harrington L S, Preusser M, Biswas S, Turley H, Heikamp E, Hainfellner JA, Harris AL: Delta-like 4 Notch ligand regulates tumour angiogene-sis, improves tumor vascular function, and promotes tumor growth in vivo. Cancer Res 2007; 67:11244-11253.
28. Chen JX, Zeng H, Lawrence ML, Blackwell TS, Meyrick B: Angiopoietin-1-induced angiogenesis is modulated by endothelial NADPH oxidase. Am J Physiol Heart Circ Physiol 2006, 291: 15 6 3-157 2.
29. Peters KG, Coogan A, Berry D, Marks J, Igle-hart JD, Kontos CD, Rao P, Sankar S, Trogan E: Expression of Tie2/Tek in breast tumour vasculature provides a new marker for evaluation of tumour angiogenesis. Br J Cancer 1998; 77: 51-56.
30. Kobayashi H, Lin PC: Angiopoietin/Tie2 signaling, tumor angiogenesis and inflammatory diseases. Front Biosci 2005; 10:666-674.
31. Post S, Peeters W, Busser E, Lamers D, Sluijter JPG, Goumans MJ, de Weger RA, Moll FL, Doevendans PA, Pasterkamp G, Vin k A: Balance between angiopoietin-1 and angiopoi-etin-2 is in favor of angiopoietin-2 in atherosclerotic plaques with high microvessel density. J Vasc Res 2008; 45:244-250.
32. Roy H, Bhardwaj S, Babu M, Kokina I, Uo-tila S, Ahtialansaari T, Laitinen T, Hakuma-ki J, Laakso M, Herzig KH, Ylä-Herttuala S: VEGF-A, VEGF-D, VEGF receptor-1, VEGF receptor-2, NF-kappa-B, and RAGE in atherosclerotic lesions of diabetic Watanabe heritable hyperlipidemic rabbits. FASEB J 2006; 20:2159-2161.
33. Boulanger E, Grossin N, Wautier MP, Taam-ma R, Wautier JL: Mesothelial RAGE activation by AGEs enhances VEGF release and potentiates capillary tube formation. Kidney Int 20 07; 71: 126-133.
34. Sasa hira T, K ir ita T, Bhawal UK, Ikeda M, Nagasawa A, Yamamoto K, Kuniyasu H: The expression of receptor for advanced glyca-tion end products is associated with angio-genesis in human oral squamous cell carcinoma. Virchows Arch 2007; 450: 287-295. (Pubitemid 46376559)
35. Moulton KS, Olsen BR, Sonn S, Fukai N, Zurakowski D, Zeng X: Loss of collagen XVIII enhances neovascularization and vascular permeability in atherosclerosis. Circulation 2004; 110: 1330-1336.
36. Ergun S, Tilki D, Oliveira-Ferrer L, Schuch G, Kilic N: Significance of vascular stabilization for tumour growth and metastasis. Cancer Lett 2006; 238:180-187.
37. Slevin M, Krupinski J, Rovira N, Turu M, Luque A, Baldellou M, Sanfeliu C, de Vera N, Badimon L: Identification of pro-angiogenic markers in blood vessels from stroke-affected brain tissue using laser-capture microdis-section. BMC Genomics 2009; 10:113.
38. Fernando NT, Koch M, Rothrock C, Gollo-gly LK, D'Amore PA, Ryeom S, Yoon SS: Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors. Clin Cancer Res 2008; 14: 1529-1539.
39. Shoji T, Koya ma H, Morioka T, Ta na ka S, K i z u A, Motoyama K, Mori K, Fukomoto S, Shioi A, Shimogaito N, Takeuchi M, Yamamoto Y, Yonekura H, Yamamoto H, Nishizawa Y: Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes. Diabetes 2006; 55: 2245-2255.
40. Morrow D, Cullen JP, Cahill PA, Redmond EM: Cyclic strain regulates Notch/CBF-1 signalling pathway in endothelial cells: role in angiogenic activity. Arterioscler Thromb Vasc Biol 2007; 27: 1289-1296.
41. Morrow D, Cullen JP, Cahill PA, Redmond EM: Ethanol stimulates endothelial cell an-giogenic activity via a Notch-and angiopoi-etin-1-dependent pathway. Cardiovasc Res 2008; 79:313-321.
42. Karamysheva AF: Mechanisms of angiogen-esis. Biochemistry (Moscow) 2008; 73: 935-948.
43. Slevin M, Badimon L, Grau-Olivares M, Ra-mis M, Sendra J, Morrison M, Krupinski J: Combining nanotechnology with current biomedical knowledge for the vascular imaging and treatment of atherosclerosis. Mol Biosyst, in press.